Wilandt Brothers UK

Home
United Kingdom
London
Wilandt Brothers UK

We deliver comprehensive HealthTech solutions. Meet the needs of your patients with our expertise, support and products.

Our personalized approach ensures optimal care. We are versatile, highly-skilled and on time, just when you need us.

26/11/2025

💡 Two therapies. One injection. Comprehensive joint support.

Monoshot™ HA+PRP combines hyaluronic acid (HA) with platelet-rich plasma (PRP) in a single intra-articular injection. The dual action provides mechanical joint support, reduction of inflammation, and initiation of tissue pro-regenerative action.

For professionals managing osteoarthritis and joint injuries, Monoshot™ HA+PRP offers a clinically proven, synergistic approach to restoring function and reducing pain.

28/10/2025

When every movement matters.

Tendon pathologies – whether acute or chronic – demand therapies that go beyond symptom control. Biolevox™ HA Tendon offers a scientifically validated approach, effectively reducing pain and enhancing tendon function. With just two injections, typically administered one week apart, physicians can provide patients with targeted treatment that combines high safety, low invasiveness, and significant clinical benefit.

10/10/2025

💡 One injection. Maximum impact.

Biolevox™ HA ONE delivers the highest amount of hyaluronic acid in a single injection – 120 mg. Developed for single-injection therapy, it effectively reduces OA symptoms, restores synovial fluid properties and helps delay the need for arthroplasty. With its pure, non-animal origin HA and excellent safety profile, Biolevox™ HA ONE offers reliable support for your patients’ mobility.

19/09/2025

When osteoarthritis accelerates, Wint™ helps slow it down.

OA triggers excessive Wnt pathway activation, which disrupts cartilage homeostasis and drives tissue degeneration. Wint™ introduces an autologous therapy that harnesses DKK-1 protein to restore biological balance within the joint. With its precision-driven mechanism, Wint™ delivers targeted support for patients, helping preserve mobility and improve quality of life.
Research on DKK-1 highlights its potential to slow OA development and preserve joint function. Wint™ represents a significant step towards improving the quality of life for OA patients.

Wint™ helps ensuring that osteoarthritis doesn’t control your patients' movement.

14/08/2025

Small joints. Specific needs. One dedicated solution.

Biolevox™ HA MINI is a tailored hyaluronic acid injection designed to meet the clinical demands of small synovial joints affected by osteoarthritis.
🔹 1 mL of highly purified sodium hyaluronate
🔹 Molecular weight: 1200–1400 kDa
🔹 Optimized viscoelastic properties for limited-joint-space injection
🔹 Indicated for OA of the ankle, wrist, CMC-1, MTP, and TMJ
The formulation supports synovial fluid function, protects cartilage, and alleviates mechanical pain associated with joint degeneration – all with minimal injection volume.

Preferred in post-surgical recovery and conservative management of early-stage OA.

01/08/2025

Not all HA is created equal.
The therapeutic potential of hyaluronic acid lies in its structure.
Biolevox™ HA products are designed with:
🔹Optimally high molecular weight
🔹Precise viscosity
🔹Targeted HA concentration for each indication
Why does it matter?
Because chain length and weight influence:
• CD44 receptor affinity
• Anti-inflammatory effect
• Clinical durability
Science doesn’t settle for “just HA.” Neither do we.

18/07/2025

Treat the tendon. Not just the pain.

Biolevox™ HA TENDON was developed to meet the specific challenges of chronic soft tissue conditions such as:
• Lateral epicondylitis
• Patellar tendinopathy
This injectable hyaluronic acid acts on a molecular level – modulating oxidative stress, inhibiting catabolic enzymes, and engaging CD44 receptors to support endogenous repair processes.

Don’t settle for temporary relief. Initiate healing where it begins – in the tissue.

02/07/2025

Combine rehabilitation with molecular support.

Post-arthroscopic joint care requires more than physiotherapy.
Biolevox™ HA 2.2% enhances outcomes by:
✅ Reducing post-procedure pain
✅ Improving joint lubrication
✅ Supporting chondrocyte growth
It’s a biomechanically compatible and clinically adaptable option for joints under recovery stress.

Trusted by professionals. Accepted by patients.

05/06/2025

Hyaluronic acid is not just lubrication. It’s a biological modulator.

The HA in Biolevox™ formulations is engineered for optimal polymer chain length – enabling it to:
🔹 Bind CD44 receptors
🔹 Trigger endogenous HA production
🔹 Modulate COX-2 and iNOS pathways
🔹 Restore collagen type II synthesis

This translates into true anti-catabolic and anti-inflammatory action at the cellular level – beyond the symptom.

Biolevox™ is not just HA – it’s a biological response inducer.

23/05/2025

Targeted HA delivery where precision matters most.

Small joints require high precision. That’s why we created Biolevox™ HA MINI – a therapy tailored for:
🔹Facet joints
🔹Ankle joints
🔹Temporomandibular joints
🔹Carpometacarpal and metatarsophalangeal joints
🔹Interphalangeal joints
With a molecular weight of 1200-1400 kDa and viscosity optimized for small joint biomechanics, Biolevox™ HA MINI ensures improved synovial fluid quality and joint function.

📈 Clinically effective, providing long-term symptom management. Therapy with Biolevox™ MINI brings significant benefits to patients, such as pain relief and quality of life improvement, which last up to 6 months.
Let science guide the therapy.

Address

590 Kingston Road SW20 8DN
London
81-061

Website

https://wilandt.uk/

Alerts

Be the first to know and let us send you an email when Wilandt Brothers UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

The Design of A Manual Well Drinking Water Pu
15 Pembroke Street, Salford
Marsurv Marine Surveys
Port Werburgh, Rochester